Nasdaq

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

ROSWELL, Ga., and WESTBROOK, Maine, June 5, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark ...
abc27

Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes

The OPTI-2 trial is a randomized, double-blind study that will enroll 220 participants to be followed over a six-month treatment period. Study subjects will utilize the Dexcom G7 Continuous Glucose ...
Nasdaq

OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

ROSWELL, Ga., and WESTBROOK, Maine, May 7, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that the United States Food and ...